Doxazosin Tablets Recalled Due to Manufacturing Practice Deviations
Preferred Pharmaceuticals recalls Doxazosin Tablets USP 2 mg (Lot H3122K, expires 5/31/2024) due to current Good Manufacturing Practice deviations identified at the manufacturing facility.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This FDA Class II recall is based on manufacturing practice deviations without reported illnesses, injuries, or identified specific product safety hazards. The source provides no evidence of harm or hospitalization, making this a precautionary regulatory-compliance-based recall.
Plain-English summary
Preferred Pharmaceuticals, Inc. is recalling Doxazosin Tablets, USP, 2 mg (NDC 68788-7328-1, 100-count bottles, Lot H3122K, Expiration 5/31/2024) manufactured by Accord Healthcare, Inc. (Durham, NC 27703) due to current Good Manufacturing Practice (cGMP) deviations identified at the manufacturing facility following an inspection.
The product was distributed nationwide. Patients who currently have this medication should contact their healthcare provider or pharmacist for guidance regarding their medication.
The recalled product
- Product
- Doxazosin Tablets, USP, 2 mg, 100-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7328-1
- Manufacturer
- Preferred Pharmaceuticals, Inc.
- Category
- Drug
- Hazard
- gmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: H3122K
- Exp 5/31/2024.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27